Servier’s treatment focus areas

Research is a priority:

 

 

More than 3000 employees working in Research and Development

 

Servier’s treatment focus areas:

Cardiovascular diseases

      • Coronary artery disease
      • Venous disease
      • Thrombosis
      • Hypertension

Metabolic diseases / Type II diabetes

Central nervous system

      • Depression
      • Anxiety
      • Schizophrenia
      • Cerebral ischemia
      • Cognitive deficits

Cancer

      • Cytotoxic agents
      • Angiogenesis
      • Cell cycle
      • Apoptosis

Osteoporosis-osteoarthritis

 

Recent innovations

Protelos, strontium ranelate

Procoralan, ivabradine

Valdoxan, agomelatine

 

Our research centers

 
 

Our 19 International Centers for Therapeutic Research (ICTRs)